Literature DB >> 18042795

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

Alexandra Traverse-Glehen1, Lucile Baseggio, Evelyne Callet- Bauchu, Dominique Morel, Sophie Gazzo, Martine Ffrench, Aurélie Verney, Delphine Rolland, Catherine Thieblemont, Jean-Pierre Magaud, Gilles Salles, Bertrand Coiffier, Françoise Berger, Pascale Felman.   

Abstract

The presence of circulating villous lymphocytes (VLs) in lymphoma patients usually points to splenic marginal zone B-cell lymphoma (SMZL), even if the VLs can be found occasionally in other small B-cell lymphomas. However, those cells are variably described, and detailed cytologic characterization is often lacking. We identified lymphoma cases with numerous basophilic VLs among the large group of splenic lymphoma with VLs, and for further delineation, 37 cases with this particular cytology were analyzed. Patients, predominantly older men, presented with moderate lymphocytosis and splenomegaly without pancytopenia. The monoclonal B cells expressed IgM + D, IgM + G, IgM or IgG, as well as CD76 and CD11c, frequently CD103, and rarely CD123. Spleen sections were peculiar, with atrophic white pulp and a monomorphic diffuse lymphoma infiltration in a congested red pulp. Bone marrow infiltration was interstitial and intrasinusoidal without extensive fibrosis. Cytogenetic analysis showed a frequent absence of clonal aberrations (68%). Most cases (79%) were IgH mutated, with an overrepresentation of V(H)3 and V(H)4 gene families. These results, as well as the clinical evolution, show that those lymphoma cases represent a homogeneous group distinct from SMZL and reminiscent of hairy cell leukemia variant, perhaps corresponding to a separate lymphoma entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042795     DOI: 10.1182/blood-2007-07-098848

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Splenic marginal zone lymphoma: hydra with many heads?

Authors:  Luca Arcaini; Marco Paulli
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Authors:  Lucile Baseggio; Alexandra Traverse-Glehen; Florence Petinataud; Evelyne Callet-Bauchu; Françoise Berger; Martine Ffrench; Chantal Marie Couris; Catherine Thieblemont; Dominique Morel; Bertrand Coiffier; Gilles Salles; Pascale Felman
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

3.  Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.

Authors:  George Kanellis; Manuela Mollejo; Santiago Montes-Moreno; Socorro-María Rodriguez-Pinilla; Juan C Cigudosa; Patricia Algara; Carlos Montalban; Estella Matutes; Andrew Wotherspoon; Miguel A Piris
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

4.  Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration.

Authors:  Ren-Ching Wang; L Jeffrey Medeiros; Kung-Chao Chang
Journal:  Int J Hematol       Date:  2018-12-05       Impact factor: 2.490

5.  A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.

Authors:  Xiaofeng Shi; Rong Ba; Haiyan You; Qian Jiang; Jiansong Huang; Jianhua Mao; Lanxiu Han; Shuo Zhang; Qin Zhuang; Xianqiu Yu; Lixia Wang; Yun Wang; Dongya Li; Wei Zhu; Yong Zhang; Yan Zhu; Xiaodong Xi
Journal:  Front Med       Date:  2017-10-27       Impact factor: 4.592

6.  CD27-positive hairy cell leukemia-Japanese variant.

Authors:  Rie Tabata; Chiharu Tabata; Hideaki Iwama; Ryoji Yasumizu; Masaru Kojima
Journal:  Virchows Arch       Date:  2016-02-11       Impact factor: 4.064

7.  Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Authors:  Scott D Dufresne; Raymond E Felgar; Rachel L Sargent; Urvashi Surti; Susanne M Gollin; Ellen D McPhail; James R Cook; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

8.  Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.

Authors:  Dong Chen; Mark E Law; Jason D Theis; Jeffrey D Gamez; Lynn B Caron; Julie A Vrana; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

9.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

10.  MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors:  Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.